Log inSign up
BioMarin
215 posts
BioMarin profile banner
@BioMarin

BioMarin

@BioMarin
A leading, global rare disease biotech company focused on delivering medicines for people living with genetically defined conditions. bit.ly/3YZNeET
biomarin.com
Joined June 2009
1
Following
824
Followers
RepliesRepliesRepostsRepostsMediaMedia

Log in or sign up for X

See what’s happening and join the conversation

Continue with phone
or
Log in with username or email
Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
  • Pinned
    @BioMarin
    BioMarin
    @BioMarin
    Dec 19, 2024
    At BioMarin, we are driven by our purpose: to be the biotech leader that translates the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The BioMarin 8 – our core Operating Principles – provide the framework for how we work
    00:00
  • @BioMarin
    BioMarin
    @BioMarin
    Aug 31
    Today we announced a global settlement with Ascendis Pharma A/S, under which Ascendis will pay royalties to BioMarin on Yuviwel sales in the U.S., EU, Brazil and South Korea. Read more: ms.spr.ly/6011arnnT
  • @BioMarin
    BioMarin
    @BioMarin
    Aug 26
    A global panel of experts has developed the first international consensus recommendations to help enable earlier and more accurate diagnosis of hypochondroplasia. Published in Nature Reviews Endocrinology, the recommendations provide a comprehensive framework that integrates
    00:00
  • @BioMarin
    BioMarin
    @BioMarin
    Aug 18
    Today we announced that we have entered into a definitive agreement to acquire Alesta Therapeutics to gain Alesta’s lead clinical stage asset, ALE1, an orally active, small molecule for the potential treatment of a rare genetic bone condition called hypophosphatasia (HPP). ALE1
    00:00
  • @BioMarin
    BioMarin
    @BioMarin
    Aug 11
    Cristin Hubbard is still motivated by the same idea that sparked her earliest interest in healthcare and eventually led her to biopharma: getting medicines to the people who need them most. At BioMarin, Cristin says she feels the impact of that commitment as strongly as ever.
    Cristin Hubbard